<ѻý>Quick Albuminuria Reduction Key Factor in Finerenone's Efficacyѻý> 4-month UACR reduction mediated 84% of kidney treatment effect Dec 05, 2023
<ѻý>Cost Hurdles Can Keep Patients From Accessing GLP-1 Receptor Agonistsѻý> Pharmacists can intervene to educate, assist with cost, two studies suggest Dec 05, 2023
<ѻý>Pharmacists Can Spur Switch to Recommended Drugs for Diabetes Patients With CVDѻý> Intervention persuaded VA physicians to adjust care, helped lower HbA1c Dec 04, 2023
<ѻý>Orphan Drug Costs; Digital Devices for Diabetesѻý> Also in TTHealthWatch: smoking cessation benefits Dec 02, 2023 podcast
<ѻý>'Alexa, Titrate My Insulin': AI App Boosts Glycemic Control in Randomized Trialѻý> Voice-based app helped users to titrate basal insulin at home Dec 01, 2023
<ѻý>Live Shingles Vaccine and Waning Immunity; Semaglutide and CV Eventsѻý> Also in TTHealthWatch: sodium and blood pressure; aspirin and LVADs Nov 18, 2023 podcast
<ѻý>Brolucizumab Noninferior to Aflibercept for Diabetic Macular Edemaѻý> At a non-approved dose, the anti-VEGF drug had similar outcomes as rival Nov 17, 2023
<ѻý>Even Small Diabetes Distress Changes Clinically Importantѻý> Researchers calculated cutoffs for significant DDS-17 scale changes Nov 15, 2023
<ѻý>One Copeptin Test More Accurate as Diagnostic for AVP Deficiencyѻý> However, this test was more complicated, with more side effects, researchers note Nov 15, 2023
<ѻý>Diabetes Linked to Higher Colorectal Cancer Riskѻý> Associated risks highest in those with recent diagnoses Nov 14, 2023
<ѻý>Some Gliflozin Side Effects Worse in Autoimmune Rheumatic Diseaseѻý> Something to consider when prescribing SGLT-2 inhibitors Nov 14, 2023
<ѻý>AMA Supports Tighter Restrictions to Curb Pollution From Industrialized Farmsѻý> Concentrated Animal Feeding Operations "may be a public health hazard," group says Nov 14, 2023
<ѻý>Tirzepatide Wins FDA Approval for Weight Lossѻý> Drug also gets a new brand name, Zepbound, for its new indication Nov 08, 2023
<ѻý>Hospitalizations After Fake Ozempic; Abortion Rights Win Big; Ketamine Use Boomsѻý> Health news and commentary from around the Web gathered by ѻý staff Nov 08, 2023
<ѻý>Kidney Week Roundup: Cell Therapy Cuts Immunosuppressive Drug Use Post-Transplantѻý> Plus: bardoxolone methyl for diabetic kidney disease and spironolactone in hemodialysis patients Nov 07, 2023
<ѻý>Novel Aldosterone Synthase Inhibitor Cuts Albuminuria in Phase II Trialѻý> Trial tested BI 690517 with and without empagliflozin Nov 06, 2023
<ѻý>Gene Therapy Controls Diabetic Eye Disease for at Least a Yearѻý> All but one patient with nonproliferative diabetic retinopathy had stable disease or improvement Nov 06, 2023
<ѻý>Eye Drops Make Bid for Role in Diabetic Macular Edemaѻý> Improved visual acuity, retinal thickness at 6 and 12 weeks, but treatment burden questioned Nov 05, 2023
<ѻý>ERA and SGLT2 Inhibitor Combo Cuts Albuminuria in Chronic Kidney Diseaseѻý> But ZENITH-CKD trial had to pivot to only using low-dose zibotentan due to fluid retention Nov 05, 2023
<ѻý>Heat and Cardiovascular Death; Time-Restricted Eating or Caloric Restriction in T2Dѻý> Also in TTHealthWatch: managing nasal airway obstruction Nov 04, 2023 podcast
<ѻý>Year in Review: Type 2 Diabetesѻý> New approvals, guidance on GLP-1s before surgery, and access issues led the news in 2023 Nov 01, 2023
<ѻý>Wegovy and Thyroid Cancer; Maine Shooter's Mental Health; 469 Heat Deathsѻý> Health news and commentary from around the Web gathered by ѻý staff Oct 30, 2023
<ѻý>Diabetic Eye Screening: Reducing Frequency May Raise Retinal Risksѻý> Switching from annual to biennial exams would delay diabetic retinopathy diagnoses, study shows Oct 27, 2023
<ѻý>Another Study Highlights Metformin's Dementia Protection Propertiesѻý> Association appeared irrespective of HbA1c level Oct 25, 2023
<ѻý>Counterfeit Ozempic; Mary Lou Retton Discharged; No Such Thing as Free Will?ѻý> Health news and commentary from around the Web gathered by ѻý staff Oct 24, 2023
<ѻý>CVS Pulls Phenylephrine Cold Meds; Doc's Murder/Suicide; Red Meat and Diabetesѻý> Health news and commentary from around the Web gathered by ѻý staff Oct 20, 2023
<ѻý>Highly Potent Statin Stands Out for Diabetes, Cataract Risksѻý> Head-to-head comparison of rosuvastatin vs atorvastatin in LODESTAR trial Oct 19, 2023
<ѻý>Gestational Diabetes Exposure in Utero Linked to Brain Changes in Kidsѻý> These changes may contribute to an increased risk of obesity in kids, researcher says Oct 18, 2023
<ѻý>Time to Recognize Cardiovascular-Kidney-Metabolic Syndrome, AHA Saysѻý> Pooled cohort equations will make way for new CKM risk calculator Oct 09, 2023
<ѻý>Inflammation of the Aorta; Afib in the Hospitalѻý> Also in TTHealthWatch: standards for osteoporosis screening and HbA1c in premenopausal women Oct 07, 2023 podcast
<ѻý>CPAP Turns in Mixed Results for Patients With Diabetic Eye Diseaseѻý> Slower progression of retinal disease, but an increase in microhemorrhages Oct 06, 2023
<ѻý>Smoking-Related Metabolic Changes Partly Drive Type 2 Diabetes Riskѻý> Those with the most metabolic changes, genetic risk had a threefold higher diabetes risk Oct 06, 2023
<ѻý>Faster-Acting Insulin Aspart Safe for Pregnant Women With Diabetesѻý> The faster formulation led to fewer hypoglycemia events versus conventional insulin aspart Oct 06, 2023
<ѻý>Hybrid Closed-Loop Insulin System for T1D Safe, Effective During Pregnancyѻý> However, no FDA-approved systems have a pregnancy indication yet Oct 05, 2023
<ѻý>Mixed Bag for Early Metformin in Gestational Diabetesѻý> EMERGE trial misses on primary endpoint, but secondary outcomes suggest potential benefit Oct 03, 2023
<ѻý>Adding Tirzepatide to Basal Insulin Cuts HbA1c in Poorly Controlled T2Dѻý> Results with the GIP/GLP-1 receptor agonist were statistically superior to added insulin lispro Oct 03, 2023
<ѻý>Pharmacists Improve Diabetes Control for Hispanic Patientsѻý> Medication-adjustment recommendations were linked to some improvements in type 2 diabetes Oct 02, 2023
<ѻý>MedPod Today: Big Medical Bill; GLP-1 Agonist Plateau; Grateful Patient Fundraisingѻý> ѻý reporters offer further insights on these recently covered topics Sep 29, 2023 podcast
<ѻý>FDA Adds Intestinal Blockage Reports to Ozempic Labelingѻý> Joins other approved GLP-1 receptor agonists in noting the potential adverse reaction Sep 28, 2023
<ѻý>Postmenopausal Fracture Risk for SGLT2 Inhibitors Similar to Other Diabetes Drugsѻý> Lower risk compared with DPP-4 inhibitors, and similar risk versus GLP-1 receptor agonists Sep 26, 2023